Nakajima Reiko, Abe Koichiro, Momose Mitsuru, Fukushima Kenji, Matsuo Yuka, Kimura Ken, Kondo Chisato, Sakai Shuji
Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Ann Nucl Med. 2017 Feb;31(2):190-197. doi: 10.1007/s12149-016-1140-5. Epub 2016 Nov 24.
C-Methionine (MET) positron emission tomography (PET) imaging is a valuable technique for the evaluation of primary and recurrent brain tumors. Many studies have used MET-PET for data acquisition starting at 20 min after the tracer injection, while others have used scan initiation times at 5-15 min postinjection. No previous studies have identified the best acquisition timing during MET-PET imaging for suspected recurrent brain tumors. Here we sought to determine the optimal scan initiating timing after MET administration for the detection of recurrent brain tumors.
Twenty-three consecutive patients with suspected recurrent brain tumors underwent MET-PET examinations. Brain PET images were reconstructed from the four serial data sets (10-15, 15-20, 20-25, and 25-30 min postinjection) that were obtained using the list-mode acquisition technique. We determined the maximal standardized uptake values (SUVmax) of the target lesions and the target-to-normal-tissue ratios (TNRs), calculated as the SUVmax to the SUVmean of a region of interest placed on the normal contralateral frontal cortex. Target lesions without significant MET uptake were excluded.
Thirty-one lesions from 23 patients were enrolled. There were no significant differences in MET SUVmax or TNR values among the PET images that were reconstructed with the data extracted from the four phases postinjection.
The MET uptake in the suspected recurrent brain tumors was comparable among all data extraction time phases from 10 to 30 min postinjection. The scan initiation time of MET-PET at 10 min after the injection is allowable for the detection of recurrent brain tumors. The registration identification number of the original study is 1002.
碳-蛋氨酸(MET)正电子发射断层扫描(PET)成像对于原发性和复发性脑肿瘤的评估是一项有价值的技术。许多研究在示踪剂注射后20分钟开始使用MET-PET进行数据采集,而其他研究则使用注射后5 - 15分钟的扫描起始时间。此前没有研究确定MET-PET成像中疑似复发性脑肿瘤的最佳采集时间。在此,我们试图确定MET给药后检测复发性脑肿瘤的最佳扫描起始时间。
连续23例疑似复发性脑肿瘤患者接受了MET-PET检查。使用列表模式采集技术获得四个连续数据集(注射后10 - 15、15 - 20、20 - 25和25 - 30分钟),并重建脑部PET图像。我们确定了靶病变的最大标准化摄取值(SUVmax)和靶组织与正常组织比值(TNR),计算方法是将SUVmax除以置于对侧正常额叶皮质感兴趣区域的SUVmean。排除MET摄取不显著的靶病变。
纳入了23例患者的31个病变。从注射后四个阶段提取的数据重建的PET图像之间,MET SUVmax或TNR值没有显著差异。
在注射后10至30分钟的所有数据提取时间阶段中,疑似复发性脑肿瘤的MET摄取相当。注射后10分钟开始MET-PET扫描对于检测复发性脑肿瘤是可行的。原始研究的注册识别号为1002。